Condition
Primary Cutaneous Vasculitis
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Colchicine
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Colchicine1
- Dapsone1
- Azathioprine1
Active Sponsors
- National Center for Advancing Translational Sciences (NCATS)1
- Office of Rare Diseases (ORD)1
- University of Pennsylvania1
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Top Investigators
University of Pennsylvania
University of Toronto/Mount Sinai Hospital
Related Conditions
- Henochschönlein Purpura1
- Cutaneous Polyarteritis Nodosa1
- Iga Vasculitis1